Literature DB >> 12600841

Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism.

Madelon M Buijs1, Jacobus Burggraaf, Carla Wijbrandts, Marieke L de Kam, Marijke Frölich, Adam F Cohen, Johannes A Romijn, Hans P Sauerwein, A Edo Meinders, Hanno Pijl.   

Abstract

BACKGROUND: Abdominal obesity is associated with a blunted lipolytic response to fasting that may contribute to the preservation of adipose tissue mass.
OBJECTIVE: To further explore the pathophysiology of blunted lipolysis during fasting in obesity, we simultaneously measured lipolysis and distinct neuroendocrine regulatory hormones in abdominally obese and normal-weight (NW) women.
DESIGN: Eight abdominally obese [x +/- SD body mass index (BMI; in kg/m(2)): 32.1 +/- 2.6] and 6 NW (BMI: 22.7 +/- 1.5) women were studied during the last 8 h of a 20-h fast. The glycerol appearance rate and the serum and plasma concentrations of insulin, leptin, cortisol, and growth hormone were measured regularly.
RESULTS: At 13 h of fasting, the mean (+/-SD) glycerol appearance rate corrected for fat mass was greater in NW women than in obese women (7.2 +/- 1.0 and 5.1 +/- 0.6 micro mol.kg(-1).min(-1), respectively; P = 0.001). After a 20-h fast, lipolysis increased to 8.9 +/- 1.5 mmol.kg(-1).min(-1) in NW women (23%), whereas it did not change significantly in obese women (-2%). Fasting decreased insulin concentrations by approximately 30% in both groups, but it did not induce significant changes in leptin concentrations. Mean cortisol concentrations and urinary catecholamine excretion were comparable in both groups. However, mean plasma growth hormone concentrations were higher in NW women than in obese women (1.81 +/- 0.98 compared with 0.74 +/- 0.52 mU/L; P = 0.046). The relative change in lipolysis tended to correlate with mean plasma growth hormone concentrations (r = 0.515, P = 0.059).
CONCLUSION: Abdominal obesity-associated hyposomatotropism may be involved in the blunted increase in lipolysis during fasting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600841     DOI: 10.1093/ajcn/77.3.544

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

2.  Unchanged mitochondrial phenotype, but accumulation of lipids in the myometrium in obese pregnant women.

Authors:  Christiane Marie Bourgin Folke Gam; Lea Hüche Larsen; Ole Hartvig Mortensen; Line Engelbrechtsen; Steen Seier Poulsen; Klaus Qvortrup; Elisabeth Reinhart Mathiesen; Peter Damm; Bjørn Quistorff
Journal:  J Physiol       Date:  2017-11-09       Impact factor: 5.182

3.  Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization.

Authors:  José L Walewski; Fengxia Ge; Michel Gagner; William B Inabnet; Alfons Pomp; Andrea D Branch; Paul D Berk
Journal:  Obes Surg       Date:  2009-10-29       Impact factor: 4.129

4.  Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.

Authors:  Andrea L Utz; Ami Yamamoto; Linda Hemphill; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

Review 5.  The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.

Authors:  Darlene E Berryman; Camilla A M Glad; Edward O List; Gudmundur Johannsson
Journal:  Nat Rev Endocrinol       Date:  2013-04-09       Impact factor: 43.330

6.  Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.

Authors:  A L Utz; A Yamamoto; P Sluss; J Breu; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

7.  GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.

Authors:  John D Carmichael; Ann Danoff; Daniela Milani; Ronenn Roubenoff; Martin L Lesser; Elayne Livote; Richard E Reitz; Steven Ferris; David L Kleinberg
Journal:  Clin Endocrinol (Oxf)       Date:  2006-08       Impact factor: 3.478

Review 8.  Fibromyalgia: symptom constellation and potential therapeutic options.

Authors:  Marjorie L Shuer
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.